M P Dore

Summary

Affiliation: University of Sassari
Country: Italy

Publications

  1. doi request reprint Miocamycin-containing triple therapy for H. pylori infection
    Maria Pina Dore
    Dipartimento di Medicina Clinica e Sperimentale, University of Sassari, Sassari, Italy
    Helicobacter 18:285-9. 2013
  2. doi request reprint [Clinical pattern of celiac disease in a population residing in North Sardinia (Italy)]
    Maria Pina Dore
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Sassari
    Recenti Prog Med 103:564-9. 2012
  3. doi request reprint Gastrointestinal symptoms and Helicobacter pylori infection in school-age children residing in Porto Torres, Sardinia, Italy
    Maria P Dore
    Dipartimento di Medicina Clinica Sperimentale ed Oncologica, University of Sassari, Sassari, Italy
    Helicobacter 17:369-73. 2012
  4. ncbi request reprint Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly
    Maria Pina Dore
    Istituto di Clinica Medica, Universita degli Studi di Sassari, Italy
    Helicobacter 11:52-5. 2006
  5. ncbi request reprint Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease
    Maria Pina Dore
    Istituto di Clinica Medica, Universita di Sassari, Viale San Pietro 8, Sassari, Italy
    Dig Dis Sci 52:463-8. 2007
  6. ncbi request reprint Cryoglobulinemia related to hepatitis C virus infection
    Maria Pina Dore
    Istituto di Clinica Medica, University of Sassari, Sassari, Italy
    Dig Dis Sci 52:897-907. 2007
  7. ncbi request reprint Diet, lifestyle and gender in gastro-esophageal reflux disease
    Maria Pina Dore
    Istituto di Clinica Medica, Universita di Sassari, Sassari, Italy
    Dig Dis Sci 53:2027-32. 2008
  8. ncbi request reprint Gastritis, dyspepsia and peptic ulcer disease
    M P Dore
    Medival Clinic Institute, University of Sassari, Sassari, Italy
    Minerva Med 99:323-33. 2008
  9. doi request reprint Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days
    Maria Pina Dore
    Istituto di Clinica Medica, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy
    Helicobacter 16:295-300. 2011
  10. ncbi request reprint Immunity markers in patients with Helicobacter pylori infection: effect of eradication
    Maria Pina Dore
    Istituto di Clinica Medica, Universita di Sassari, Italy
    Helicobacter 10:391-7. 2005

Collaborators

Detail Information

Publications25

  1. doi request reprint Miocamycin-containing triple therapy for H. pylori infection
    Maria Pina Dore
    Dipartimento di Medicina Clinica e Sperimentale, University of Sassari, Sassari, Italy
    Helicobacter 18:285-9. 2013
    ..pylori infection have an average cure rate of 57% largely due to a high prevalence of antimicrobial resistance. The efficacy of miocamycin-containing treatment for 10 days was evaluated...
  2. doi request reprint [Clinical pattern of celiac disease in a population residing in North Sardinia (Italy)]
    Maria Pina Dore
    Dipartimento di Medicina Clinica e Sperimentale, Universita di Sassari
    Recenti Prog Med 103:564-9. 2012
    ..To recognize atypical symptoms could be the most important step in the diagnosis and further treatment...
  3. doi request reprint Gastrointestinal symptoms and Helicobacter pylori infection in school-age children residing in Porto Torres, Sardinia, Italy
    Maria P Dore
    Dipartimento di Medicina Clinica Sperimentale ed Oncologica, University of Sassari, Sassari, Italy
    Helicobacter 17:369-73. 2012
    ..Helicobacter pylori infection is typically acquired in childhood, and following the acute event, it is thought that most infections remain asymptomatic. H. pylori has been suggested to protect against diarrhea in childhood...
  4. ncbi request reprint Twice-a-day quadruple therapy for eradication of Helicobacter pylori in the elderly
    Maria Pina Dore
    Istituto di Clinica Medica, Universita degli Studi di Sassari, Italy
    Helicobacter 11:52-5. 2006
    ..Aim: The objective of our study was to estimate the efficacy, side-effects, and compliance of a quadruple therapy containing esomeprazole in a group of dyspeptic elderly patients...
  5. ncbi request reprint Effect of antisecretory therapy on atypical symptoms in gastroesophageal reflux disease
    Maria Pina Dore
    Istituto di Clinica Medica, Universita di Sassari, Viale San Pietro 8, Sassari, Italy
    Dig Dis Sci 52:463-8. 2007
    ..We conclude that atypical symptoms are frequent in patients with GERD. A trial of PPI therapy should be considered prior to referring these patients to specialists...
  6. ncbi request reprint Cryoglobulinemia related to hepatitis C virus infection
    Maria Pina Dore
    Istituto di Clinica Medica, University of Sassari, Sassari, Italy
    Dig Dis Sci 52:897-907. 2007
    ..Novel treatment with rituximab is promising...
  7. ncbi request reprint Diet, lifestyle and gender in gastro-esophageal reflux disease
    Maria Pina Dore
    Istituto di Clinica Medica, Universita di Sassari, Sassari, Italy
    Dig Dis Sci 53:2027-32. 2008
    ..Studies indicate that gastro-esophageal reflux disease (GERD) is associated with obesity, smoking, esophagitis, diet, and lifestyle...
  8. ncbi request reprint Gastritis, dyspepsia and peptic ulcer disease
    M P Dore
    Medival Clinic Institute, University of Sassari, Sassari, Italy
    Minerva Med 99:323-33. 2008
    ..g., 55 years in Western countries). Patients negative for H. pylori infection should receive an empiric trial of acid suppression for 4 to 8 weeks and if beneficial it can be continued...
  9. doi request reprint Twice-a-day bismuth-containing quadruple therapy for Helicobacter pylori eradication: a randomized trial of 10 and 14 days
    Maria Pina Dore
    Istituto di Clinica Medica, University of Sassari, Viale San Pietro 8, 07100 Sassari, Italy
    Helicobacter 16:295-300. 2011
    ..pylori eradication therapy. Aim:  To compare the efficacy and tolerability of twice-a-day bismuth-containing quadruple H. pylori eradication therapy for 10 versus 14 days in a noninferiority trial...
  10. ncbi request reprint Immunity markers in patients with Helicobacter pylori infection: effect of eradication
    Maria Pina Dore
    Istituto di Clinica Medica, Universita di Sassari, Italy
    Helicobacter 10:391-7. 2005
    ..Helicobacter pylori is a microorganism able to stimulate a robust inflammatory and systemic immune response...
  11. ncbi request reprint Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection
    M P Dore
    Institute of Internal Medicine, University of Medicine, Sassari, Italy
    Aliment Pharmacol Ther 12:635-9. 1998
    ..The aim of this study was to assess the role of pre-treatment amoxycillin resistance in the efficacy of omeprazole and amoxycillin dual therapy...
  12. ncbi request reprint Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies
    G Realdi
    Department of Internal Medicine, University of Sassari, Italy
    Helicobacter 4:106-12. 1999
    ..The aim of this study was to evaluate the relation between pretreatment antibiotic resistance and outcome by using six different treatment regimens for H. pylori infection...
  13. ncbi request reprint Colloidal bismuth subcitrate-based twice-a-day quadruple therapy as primary or salvage therapy for Helicobacter pylori infection
    M P Dore
    Institute of Internal Medicine, University of Medicine, Sassari, Italy
    Am J Gastroenterol 97:857-60. 2002
    ..e., a proton pump inhibitor and two antibiotics) are typically <60%, primarily because of antibiotic resistance. The aim of this study was to test b.i.d. quadruple therapy as primary and as salvage therapy in this population...
  14. ncbi request reprint Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms
    A Pironti
    Departiment of Clinical Medicine, University of Sassari, Sassari, Italy
    Minerva Med 101:129-34. 2010
    ..The aim of the study was to evaluate whether routine duodenal biopsy sampling of macroscopically normal mucosa of patients with irritable bowel syndrome-like symptoms undergoing upper endoscopy assists in diagnosis and management...
  15. ncbi request reprint Diabetes mellitus and Helicobacter pylori infection
    M P Dore
    Department of Internal Medicine, University of Sassari, Sassari, Italy
    Nutrition 16:407-10. 2000
    ..Because childhood is the most common period for acquisition of H. pylori infection, the higher prevalence of infection among the normal children as opposed to those with type-1 diabetes confirms the lack of an association...
  16. ncbi request reprint Ulcers and gastritis
    M P Dore
    Institute of Clinical Medicine, University of Sassari, Sassari, Italy
    Endoscopy 36:42-7. 2004
    ..pylori-associated gastric cancer...
  17. ncbi request reprint Sheep rearing and Helicobacter pylori infection--an epidemiological model of anthropozoonosis
    M P Dore
    Institute of Clinical Medicine University of Sassari, Viale San Pietro, 8 Sassari 07100, Italy
    Dig Liver Dis 35:7-9. 2003
  18. ncbi request reprint Genomic instability in chronic viral hepatitis and hepatocellular carcinoma
    M P Dore
    Institutes of Internal Medicine, Pathology, and General Surgery, University of Medicine, Sassari, Italy
    Hum Pathol 32:698-703. 2001
    ..2) occurs frequently in chronic hepatitis, suggesting that genomic alterations affecting the long arm of chromosome 13 might be used to monitor the natural progression of chronic hepatitis-associated liver carcinogenesis...
  19. doi request reprint Proteomic characterization of hepatitis C eradication: enzyme switch in the healing liver
    S Babudieri
    Infectious Diseases Unit, Department of Clinical and Experimental Medicine, University of Sassari, Italy
    J Clin Virol 57:274-8. 2013
    ..The same enzyme deficit is completely recovered after HCV eradication...
  20. doi request reprint Correlation between nasal mucociliary clearance time and gastroesophageal reflux disease: our experience on 50 patients
    E Delehaye
    University Department of Otolaryngology Head and Neck Surgery, University of Sassari, Italy
    Auris Nasus Larynx 36:157-61. 2009
    ..The aim of our study was to evaluate the nasal mucociliary clearance time in GERD patients and if any correlations could be assumed...
  21. ncbi request reprint The QUADRATE study: a proposal for a change in the reporting of pharmaceutical supported trials
    David Y Graham
    Gastroenterology 125:639; author reply 640-1. 2003
  22. ncbi request reprint Salvage therapy after two or more prior Helicobacter pylori treatment failures: the super salvage regimen
    Maria Pina Dore
    Institute of Internal Medicine, University of Medicine, Sassari, Italy
    Helicobacter 8:307-9. 2003
    ..Although effective therapies are available for curing Helicobacter pylori infection, the problem persists about what to do for patients who fail two or more treatment courses despite a good compliance...
  23. ncbi request reprint Interplay between Helicobacter pylori and host gene polymorphisms in inducing oxidative DNA damage in the gastric mucosa
    Alberto Izzotti
    Department of Health Sciences, University of Genoa, Via A Pastore 1, I 16132, Genoa, Italy
    Carcinogenesis 28:892-8. 2007
    ..The interplay between bacterial and host gene polymorphisms may explain why gastric cancer only occurs in a small fraction of H.pylori-infected individuals...
  24. ncbi request reprint Novel monoclonal antibody-based Helicobacter pylori stool antigen test
    Maria Pina Dore
    Institute of Internal Medicine, Spedali Civili, Brescia, Italy
    Helicobacter 9:228-32. 2004
    ..Recently, a monoclonal antibody-based stool antigen test demonstrated an excellent performance in diagnosing H. pylori infection in adults and in pediatric populations...
  25. ncbi request reprint Active peptic ulcer disease in patients with hepatitis C virus-related cirrhosis: the role of Helicobacter pylori infection and portal hypertensive gastropathy
    Maria Pina Dore
    Istituto di Clinica Medica, Universita degli Studi di Sassari, Italy
    Can J Gastroenterol 18:521-4. 2004
    ....